Matches in Wikidata for { <http://www.wikidata.org/entity/Q92577513> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q92577513 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92577513 description "scientific article published on 06 June 2019" @default.
- Q92577513 description "wetenschappelijk artikel" @default.
- Q92577513 description "наукова стаття, опублікована 6 червня 2019" @default.
- Q92577513 name "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 name "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 type Item @default.
- Q92577513 label "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 label "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 prefLabel "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 prefLabel "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 P1433 Q92577513-965DA0C5-F2F0-4A64-B80F-A45B98032CA3 @default.
- Q92577513 P1476 Q92577513-478D604C-175B-487B-937C-25E90EF39C3C @default.
- Q92577513 P2093 Q92577513-1D1FDCCA-0518-4AFC-A214-0C3489F3C247 @default.
- Q92577513 P2093 Q92577513-452E491A-5612-494C-93D4-552E7720DBA6 @default.
- Q92577513 P2093 Q92577513-89308805-5142-4B31-AD8A-7DE14E8608F3 @default.
- Q92577513 P2093 Q92577513-897B3198-7046-4B44-A09D-F77F5520F640 @default.
- Q92577513 P2093 Q92577513-95320697-118F-491F-AAEC-E102A14AAD14 @default.
- Q92577513 P2093 Q92577513-B59F147D-35A6-451C-A3F9-F60CE8EC4BE0 @default.
- Q92577513 P304 Q92577513-8F9197FB-7DDD-4774-B0F8-636A8548461C @default.
- Q92577513 P31 Q92577513-F64CE496-0787-436D-A963-CBAA57CA17F6 @default.
- Q92577513 P356 Q92577513-E17A5A4D-34D4-4199-9589-3AEDB8A94C6F @default.
- Q92577513 P433 Q92577513-76EC8898-EA78-4E3C-9967-D16085338B8B @default.
- Q92577513 P478 Q92577513-3FF94EEA-F88A-48A7-8465-EF6BCFCCDAFA @default.
- Q92577513 P50 Q92577513-84EEBB16-FF59-42E5-A01C-84D270116C01 @default.
- Q92577513 P50 Q92577513-980FEE6F-8FAB-412F-AFCA-E4F8E106BF8B @default.
- Q92577513 P577 Q92577513-D32F2FDD-AA51-4AD6-9771-B5606CE394FE @default.
- Q92577513 P698 Q92577513-AA8DC6E2-B3DE-4054-936A-6A2A8CE44FDF @default.
- Q92577513 P921 Q92577513-68AFAB4B-4B73-4B1B-B806-D6A518487C6D @default.
- Q92577513 P356 JCB.29111 @default.
- Q92577513 P698 31172597 @default.
- Q92577513 P1433 Q6294917 @default.
- Q92577513 P1476 "Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival" @default.
- Q92577513 P2093 "Duangnapa Kiriwan" @default.
- Q92577513 P2093 "Pichamon Kiatwuthinon" @default.
- Q92577513 P2093 "Pimonwan Srisook" @default.
- Q92577513 P2093 "Praphasri Suphakun" @default.
- Q92577513 P2093 "Siratcha Phanthong" @default.
- Q92577513 P2093 "Wanpen Chaicumpa" @default.
- Q92577513 P304 "18077-18087" @default.
- Q92577513 P31 Q13442814 @default.
- Q92577513 P356 "10.1002/JCB.29111" @default.
- Q92577513 P433 "10" @default.
- Q92577513 P478 "120" @default.
- Q92577513 P50 Q56881876 @default.
- Q92577513 P50 Q92244929 @default.
- Q92577513 P577 "2019-06-06T00:00:00Z" @default.
- Q92577513 P698 "31172597" @default.
- Q92577513 P921 Q356033 @default.